Navigation Links
PURE Bioscience Announces Distribution Agreement With Orchem Corporation
Date:7/15/2008

NBA Hall of Fame Legend Oscar Robertson's Leading Specialty Chemical

Company will Market 'Powered by SDC' Spectrum 24 Disinfectant

SAN DIEGO, Calif., July 15 /PRNewswire-FirstCall/ -- PURE Bioscience (Nasdaq: PURE) today announced an agreement with Orchem Corporation for distribution of PURE's silver dihydrogen citrate (SDC)-based disinfectant under Orchem's Spectrum 24(TM) brand.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO)

Owned by Hall of Fame basketball legend Oscar Robertson, Cincinnati-headquarted Orchem Corporation is the leading minority-owned specialty chemical manufacturer in the United States. Orchem has extensive expertise in proprietary product formulation, contract manufacturing and distribution services and provides state-of-the art proprietary formulated specialty cleaning and sanitizing solutions to the food, beverage, dairy processing, institutional, healthcare, general industrial, residential and commercial markets.

Michael L. Krall, president and CEO of PURE Bioscience said, "A focused marketing program and commitment to educating its customers make Orchem an ideal distributor for our SDC-based disinfectant. In addition, we appreciate the passion with which Orchem leads the specialty chemical industry in product quality and innovation while promoting safety and protecting the environment. Orchem has achieved outstanding and growing success in several key markets where SDC can provide immediate solutions and we look forward to a very successful launch of Spectrum 24."

According to Kenneth Munson, vice president sales and marketing for Orchem Corporation, Spectrum 24 will pl
'/>"/>

SOURCE PURE Bioscience
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...swire/ -- Biotech firm Replikins Ltd., which has a... pandemic through the prediction, outbreak, and pr...its latest biochemical analysis of the virus. The ...ine Flu") virus has dropped from its peak of 3.7 (...he spring of 2009 to resting non-epidemic levels t...
(Date:11/25/2009)...wire/ - Cytochroma today announced the appointment.... Moldt will replace Mr. Ulrik Spork as the Novo A...er of Board members remains unchanged at six membe...ldt to the board and look forward to benefiting fr...nues to make progress in becoming a leading CKD-fo...
(Date:11/25/2009)...ire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq:...m.D., president and chief executive officer, will ...re Conference. , ,Presentation details are as fol...rence,Date: Tuesday, December 1, 2009,Time: ... Palace Hotel, New York, NY,Webcast: <a href=,h...
(Date:11/24/2009)...also Visit Detroit , (Voc...ench Ambassador for International Investment, and ... , , ,What: Ambassador Appia is available to meet...ives adopted by France to further develop the fina...n and development., , ,When: Available for Intervi...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...Soliris(R) Sales Reflect Strong 2007 Launch; Posit... U.S. and International Markets, Fourth Quarter...ulizumab) net product sales were $33.9 million in ... million in Q3 2007., * Q4 GAAP net loss was $12....AP net loss of $20.1 million, or $0.55 per share, ...
...Three-Year Extension for Integrated Drug Discovery...s for the Treatment of Huntington Disease, HAMBUR...ornia, February,14 Evotec AG (Frankfurt Stock Exc...Inc., a not-for-profit organization,pursuing a bio...Disease,(HD), has extended its collaboration with ...
..., Nanotechnology researchers are developing the p...able to generate electricity to power small electr... others whose physical motion could be harnessed a... 14 issue of the journal Nature details how pairs ...s can generate electrical current using the piezoe...
Other Biology Technology:Alexion Reports Fourth Quarter and Full Year 2007 Results 2Alexion Reports Fourth Quarter and Full Year 2007 Results 3Alexion Reports Fourth Quarter and Full Year 2007 Results 4Alexion Reports Fourth Quarter and Full Year 2007 Results 5Alexion Reports Fourth Quarter and Full Year 2007 Results 6Alexion Reports Fourth Quarter and Full Year 2007 Results 7Alexion Reports Fourth Quarter and Full Year 2007 Results 8Alexion Reports Fourth Quarter and Full Year 2007 Results 9Alexion Reports Fourth Quarter and Full Year 2007 Results 10Alexion Reports Fourth Quarter and Full Year 2007 Results 11Alexion Reports Fourth Quarter and Full Year 2007 Results 12Alexion Reports Fourth Quarter and Full Year 2007 Results 13Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million 2Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million 3Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million 4Fiber-based nanotechnology in clothing could harvest energy from physical movement 2Fiber-based nanotechnology in clothing could harvest energy from physical movement 3Fiber-based nanotechnology in clothing could harvest energy from physical movement 4
(Date:11/30/2009)...of lower early bird registration rates and registe...s of 2010 at http://www.iofwco-ecceo10.org/ , ...International Osteoporosis Foundation (IOF) and th...ts of Osteoporosis and Osteoarthritis (ESCEO). Mor...e expected to attend. The exciting scientific prog...
(Date:11/30/2009)...lorless and odorless radioactive gas that is produ...a product of uranium decay and is found in trace a...roundwater as well as building materials, plants, ...ion is expressed as the amount of radiation that w... a liter of air; thus the units are picocuries per...
(Date:11/26/2009).... (November 26, 2009) Whitehead researchers have ...ells to pinpoint specific genes and proteins used ... . , In most human cell cultures genes are prese...d one from the mother. Gene inactivation by mutati...is inactivated, the second copy usually remains ac...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Knockouts in human cells point to pathogenic targets 2U S Court of Appeals Upholds AstraZeneca AWP Settlement 6446 1U S Court of Appeals Upholds AstraZeneca AWP Settlement 6446 2U S Court of Appeals Upholds AstraZeneca AWP Settlement 6446 3Spanish biotechnology should focus on food and plant sectors to be more competitive 14936 1Spanish biotechnology should focus on food and plant sectors to be more competitive 14936 2H1N1 Pandemic May Have Peaked in October in U S According to Quest Diagnostics 61864 1H1N1 Pandemic May Have Peaked in October in U S According to Quest Diagnostics 61864 2H1N1 Pandemic May Have Peaked in October in U S According to Quest Diagnostics 61864 3
... capable of metacognition—that is, they can posses...ility, which can also be thought of as the capacit...es, was previously only recognized in humans and o...n Foote and Jonathon Crystal of the University of ...iology, published by Cell Press, on March 8th. , A...
...n ovarian cancer may present a new target for diag...ccording to researchers at the University of Illin...f Pharmacy found that interfering with the product...d invasiveness of tumor cells in test-tube experim...human ovarian tumors overexpressed polypyrimidine ...
...om the lungs of transplant patients demonstrates f...de in adult organs and are not derived from bone m...ls may be able to help with the rejection of donat... , The study by University of Michigan Health Syst... number of lung transplant patients who experience...
Other Biology News:Metacognition: Faced with a test, rats can check their knowledge first 2RNA splicing factor implicated in ovarian tumor cell growth 2Type of stem cell found to reside in transplanted lungs 2Type of stem cell found to reside in transplanted lungs 3
Anti-Yersinia pestis Monoclonal Antibody, Unconjugated from ViroStat Inc.
Rabbit Anti-Olfactory Receptor LS189744 Polyclonal Antibody, Unconjugated from Abcam
Anti-Varicella-zoster Virus, Nucleocapsid Protein Monoclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Zeralenone Monoclonal Antibody, Unconjugated, Clone 11C9 from Abcam
Biology Products: